Valent BioSciences announced Tuesday it is making investments at three research and development facilities in addition to the recently announced expansions at the company’s manufacturing facility in Osage. Additions at the Osage plant include new production-scale fermentation and recovery equipment, a new pilot plant facility and expanded laboratory space. The biotechnology company will also restore 34 acres of prairie land, which will sequester carbon dioxide, and construct a solar field, both near the Osage facility.
Other domestic expansions will be at the Biorational Research Center in Libertyville, Ill., and the Bio Research & Development Growth Park at the Donald Danforth Plant Science Center in St. Louis.
Additionally, in late 2020, Valent Biosciences established a dedicated Biorational Unit at parent company Sumitomo Chemical Co., Ltd.’s Health & Crop Sciences Research Laboratory in Japan. According to a news release, the collaboration enables Valent BioSciences to broaden its biorational research programs and activities and launch various synthetic biology projects. Read more about Valent BioScience’s Osage expansion in the innovationIOWA Magazine.